Interleukin-17D deficiency attenuates atherosclerosis by diminishing macrophage inflammation and promoting M2 phenotype
European Journal of Pharmacology · 2026-12 · 1039 · 179482
DOI: 10.1016/j.ejphar.2026.179482 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2026-12. Verfasst von Jingyuan Hou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Diseases, Meizhou People's Hospital, Affiliated Meizhou Hospital of Shantou University Medical College, Meizhou, Guangdon…. Hauptthemen laut MEDLINE: Macrophages, Atherosclerosis, Interleukin-17, Inflammation. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
INTRODUCTION: Macrophages are central to atherosclerosis by driving vascular inflammation, plaque growth, and instability. Although interleukin-17D (IL-17D) has been linked to endothelial inflammation, its role in macrophage-mediated atherosclerosis remains unclear. OBJECTIVES: This study investigated the function and mechanism of macrophage IL-17D in atherosclerosis. METHODS: Using IL-17D knockout, macrophage-specific IL-17D knockdown, and macrophage-specific Spi-B knockdown mouse models on an ApoE-/- background, we assessed aortic lesion burden, necrotic core formation, macrophage accumulation, inflammatory responses, and macrophage polarization. Mechanistic studies were performed using transcriptomic analysis, ChIP-PCR, and luciferase reporter assays. RESULTS: IL-17D deficiency markedly reduced atherosclerotic plaque formation in the whole aorta and aortic root, decreased necrotic core size, and limited macrophage accumulation and vascular inflammation. Both in vitro and in vivo, IL-17D deficiency promoted M2 macrophage polarization while suppressing pro-inflammatory cytokines and chemokines. Macrophage-specific IL-17D knockdown similarly attenuated atherosclerotic lesion development and inflammation. Mechanistically, IL-17D deficiency activated the Spi-B-STAT6 transcriptional axis. Macrophage-specific Spi-B knockdown reversed the anti-atherosclerotic effects of IL-17D deficiency, confirming its functional importance. Rosuvastatin suppressed IL-17D expression, and IL-17D repression contributed to its anti-inflammatory and anti-atherogenic effects. CONCLUSIONS: These findings identify macrophage-derived IL-17D as a key regulator of atherosclerosis. Targeting IL-17D may promote protective M2 polarization and alleviate vascular inflammation, offering a potential therapeutic strategy for atherosclerotic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cardiovascular Diseases, Meizhou People's Hospital, Affiliated Meizhou Hospital of Shantou University Medical College, Meizhou, Guangdong, China; Guangdong Provincial Engineering and Technological Research…
- Institute of Basic Medical Sciences, Meizhou People's Hospital, Affiliated Meizhou Hospital of Shantou University Medical College, Meizhou, Guangdong, China; Guangdong Provincial Engineering and Technological Research C…
- Institute of Basic Medical Sciences, Meizhou People's Hospital, Affiliated Meizhou Hospital of Shantou University Medical College, Meizhou, Guangdong, China.
- Department of Radiology, Meizhou People's Hospital, Affiliated Meizhou Hospital of Shantou University Medical College, Meizhou, Guangdong, China.
- Department of Cardiology, Meizhou People's Hospital, Affiliated Meizhou Hospital of Shantou University Medical College, Meizhou, Guangdong, China; Meizhou Key Laboratory of Cardiovascular Translational Medicine, Meizhou…
Förderung
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Hou, J., Gu, X., Li, X., Zhao, J., Weng, R., Deng, Q., Guo, J., Zhong, W., Huang, Q., & Liu, S. (2026). Interleukin-17D deficiency attenuates atherosclerosis by diminishing macrophage inflammation and promoting M2 phenotype. European Journal of Pharmacology, 1039, 179482. https://doi.org/10.1016/j.ejphar.2026.179482
Vancouver
Hou J, Gu X, Li X, Zhao J, Weng R, Deng Q, et al. Interleukin-17D deficiency attenuates atherosclerosis by diminishing macrophage inflammation and promoting M2 phenotype. European Journal of Pharmacology. 2026;1039:179482. doi:10.1016/j.ejphar.2026.179482
BibTeX
@article{Hou2026,
author = {Hou, Jingyuan and Gu, Xiaodong and Li, Xia and Zhao, Junli and Weng, Ruiqiang and Deng, Qiaoting and Guo, Jianbo and Zhong, Wei and Huang, Qionghui and Liu, Sudong},
title = {Interleukin-17D deficiency attenuates atherosclerosis by diminishing macrophage inflammation and promoting M2 phenotype},
journal = {European Journal of Pharmacology},
year = {2026},
volume = {1039},
pages = {179482},
doi = {10.1016/j.ejphar.2026.179482}
}
EUVIMED